Phase
Condition
Bipolar Disorder
Depression
Depression (Major/severe)
Treatment
N/AClinical Study ID
Ages 18-64 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Depressed participants:
Right-handed
DSM-IV diagnosis of MDD
Score of at least 17 on the 21-item HAM-D scale
Absence of any psychotropic medications for at least 2 weeks (6 months fordopaminergic drugs (including methylphenidate), 6 weeks for fluoxetine, and 4 weeksfor neuroleptics and benzodiazepines because of longer half-lives.)
No current or past history of MDD with psychotic features
Absence of any other Axis I or Axis II diagnosis (Including bipolar disorder andcurrent or lifetime history of alcohol or substance abuse or dependence.)Particularly, subjects with a history of alcoholism and substance abuse will beexcluded, since dopaminergic alterations have been reported in these conditions.Exclusion of patients with comorbid Axis I or Axis II diagnoses will be necessary asevidence exists of alteration in dopamine receptor density in detached personality andsocial phobia. The alteration of dopamine in the brain may in turn alter behavior.
Absence of significant medical conditions
Absence of ECT in the previous 6 months
Ability to provide informed consent/authorization Bipolar participants:
Both genders and all ethnic origins
Age between 18 and 64
Right-handed
DSM-IV diagnosis of Bipolar Disorder I or II
Score of at least 17 on the 21-item Hamilton Depression Rating Scale (HAM-D)
Absence of any psychotropic medications for at least 2 weeks (6 months fordopaminergic drugs (including methylphenidate), 6 weeks for fluoxetine, and 4 weeksfor neuroleptics and benzodiazepines because of longer half-lives.)
No current or past history of MDD with psychotic features
Absence of any other Axis I or Axis II diagnosis (Including current or lifetimehistory of alcohol or substance abuse or dependence.) Particularly, subjects with ahistory of alcoholism and substance abuse will be excluded.
Absence of significant medical conditions
Absence of ECT in the previous 6 months
Ability to provide informed consent/authorization Control Participants:
Right-handed
Absence of medical, neurological, and psychiatric illness (including alcohol andsubstance abuse), as assessed by the SCID
Absence of any medications for at least 2 weeks
Informed consent/authorization
Exclusion
Exclusion Criteria:
Left-handed/ambidextrous
Evidence of neurological illness
Current alcohol or substance abuse
Serious suicide or homicide risk
Study Design
Study Description
Connect with a study center
The Depression Clinical and Research Program, Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available
Affective Neuroscience Laboratory, Department of Psychology, Harvard University
Cambridge, Massachusetts 02138
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.